[esi adrotate group="1" cache="private" ttl="0"]

Andrew Gallagher

About
Latest Posts

Andrew Gallagher is chief operating officer at Phynova, a British life science company that develops and sells medically licensed drugs, functional ingredients and cosmeceuticals derived from active compounds found in plants.

Latest posts by Andrew Gallagher (see all)

Licensing traditional Chinese medicines - 15th September 2016

Licensing traditional Chinese medicines

Addiction, Mental Health
New study challenges social media’s mental health impact
New study challenges social media’s mental health impact – A new Curtin University study has challenged the perception …
Global Reach, neurology
Do Finland introduces a new care pathway for …
Do Finland introduces a new care pathway for epilepsy – The Finnish epilepsy care pathway has been published …
Muscular & Skeletal, neurology
Innovative swim program for people with cerebral palsy
Innovative swim program for people with cerebral palsy – A competitive swimming program developed by University of Queensland …
Environment, Global Reach
Biotech project to protect food growers from pests
Biotech project to protect food growers from pests – A new $24.79 million project is poised to revolutionise …
Heart & Lung
Heart Attacks and Cardiac Arrests – What’s the …
Heart Attacks and Cardiac Arrests – What’s the Difference? Advice from the leading UK Provider of Online First …

The Royal Society of Medicine blogs

View all posts from The RSM »

LATEST: Medicine and Me, Bowel Research UK Seminar